Annual Shareholders Equity
-$2.10 M
-$9.34 M-129.07%
31 December 2023
Summary:
Qualigen Therapeutics annual stockholders equity is currently -$2.10 million, with the most recent change of -$9.34 million (-129.07%) on 31 December 2023. During the last 3 years, it has fallen by -$20.40 million (-111.50%). QLGN annual shareholders equity is now -111.50% below its all-time high of $18.29 million, reached on 01 December 2020.QLGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$2.14 M
+$2.14 M+49.95%
30 September 2024
Summary:
Qualigen Therapeutics quarterly stockholders equity is currently -$2.14 million, with the most recent change of +$2.14 million (+49.95%) on 30 September 2024. Over the past year, it has dropped by -$500.30 thousand (-30.49%). QLGN quarterly shareholders equity is now -112.92% below its all-time high of $16.56 million, reached on 31 December 2021.QLGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -129.1% | -30.5% |
| 3 y3 years | -111.5% | -119.7% |
| 5 y5 years | - | - |
QLGN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -111.5% | at low | -112.9% | +50.0% |
| 5 y | 5 years | -111.5% | at low | -112.9% | +83.7% |
| alltime | all time | -111.5% | at low | -112.9% | +83.7% |
Qualigen Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$2.14 M(-50.0%) |
| June 2024 | - | -$4.28 M(+21.5%) |
| Mar 2024 | - | -$3.52 M(+67.4%) |
| Dec 2023 | -$2.10 M(-129.1%) | -$2.10 M(+28.2%) |
| Sept 2023 | - | -$1.64 M(-180.7%) |
| June 2023 | - | $2.03 M(-58.2%) |
| Mar 2023 | - | $4.87 M(-32.7%) |
| Dec 2022 | $7.24 M | $7.24 M(-40.4%) |
| Sept 2022 | - | $12.15 M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $14.47 M(+7.1%) |
| Mar 2022 | - | $13.52 M(-18.4%) |
| Dec 2021 | $16.56 M(-9.5%) | $16.56 M(+52.7%) |
| Sept 2021 | - | $10.85 M(-11.5%) |
| June 2021 | - | $12.26 M(-24.5%) |
| Mar 2021 | - | $16.23 M(-661.9%) |
| Dec 2020 | $18.29 M(-1049.0%) | - |
| Sept 2020 | - | -$2.89 M(-78.0%) |
| June 2020 | - | -$13.15 M |
| Mar 2020 | -$1.93 M | - |
FAQ
- What is Qualigen Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual shareholders equity year-on-year change?
- What is Qualigen Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly shareholders equity year-on-year change?
What is Qualigen Therapeutics annual stockholders equity?
The current annual shareholders equity of QLGN is -$2.10 M
What is the all time high annual shareholders equity for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual stockholders equity is $18.29 M
What is Qualigen Therapeutics annual shareholders equity year-on-year change?
Over the past year, QLGN annual stockholders equity has changed by -$9.34 M (-129.07%)
What is Qualigen Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of QLGN is -$2.14 M
What is the all time high quarterly shareholders equity for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly stockholders equity is $16.56 M
What is Qualigen Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, QLGN quarterly stockholders equity has changed by -$500.30 K (-30.49%)